Crinetics Pharmaceuticals, Inc. (CRNX) Balance sheet

Market cap

$7.8B

P/E ratio

	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	45	41	94	201	34	56	266
Marketable securities, current	119	78	78	133	302	504	1,090
Total cash & short-term investments	164	119	171	334	336	560	1,355
Total current assets	167	123	177	345	345	574	1,375
Property, plant and equipment, net	4	4	3	3	4	11	12
Total non-current assets	5	7	6	6	7	61	59
Total assets	171	130	183	351	352	635	1,435
Accounts payable	1	-	-	-	-	-	-
Total current liabilities	8	8	10	16	28	44	60
Total non-current liabilities	3	5	4	3	8	52	50
Total liabilities	11	13	15	19	36	96	110
Common stock and paid-in capital	204	211	337	608	759	1,192	2,276
Retained earnings	-43	-94	-168	-275	-439	-654	-952
Stockholders' equity	160	117	169	332	316	539	1,325